Mayo Clinic proceedings
-
Mayo Clinic proceedings · Jun 2010
Randomized Controlled TrialLong-term maintenance treatment of restless legs syndrome with gabapentin enacarbil: a randomized controlled study.
To assess maintenance of efficacy and tolerability of gabapentin enacarbil in patients with moderate to severe primary restless legs syndrome (RLS). ⋯ Gabapentin enacarbil, 1200 mg, maintained improvements in RLS symptoms compared with placebo and showed long-term tolerability in adults with moderate to severe primary RLS for up to 9 months of treatment.